Nia Health GmbH
About us
Nia Health is a digital health technology company specializing in advanced medical research solutions, emerging from the interdisciplinary research ecosystem of Charité - Universitätsmedizin Berlin, a globally recognized center for medical innovation.
Our portfolio includes CE-certified medical device applications for chronic inflammatory skin conditions, specifically developed for patients with atopic dermatitis and psoriasis. These medical-grade digital monitoring platforms provide certified medical documentation and patient management tools, setting new standards in digital therapeutics.
Our proprietary platform combines machine vision AI and advanced machine learning to revolutionize medical research and patient monitoring. By delivering objective, quantifiable assessments across multiple medical domains, we enable precise dermatological, immunological, and pharmaceutical research insights.
Key technological innovations include:
AI-powered severity classification
Real-time disease progression tracking
Smartphone and web-based monitoring tools
Predictive treatment response analytics
The platform offers comprehensive solutions for pharmaceutical companies, enabling:
Precise clinical trial patient screening
Objective treatment effectiveness measurement
Automated data collection
Privacy-compliant patient monitoring
Our machine vision technology can assess conditions across dermatology, wound management, oncology, and infectious disease tracking, providing unprecedented insights into disease progression and treatment responses. By seamlessly integrating advanced imaging technologies with sophisticated data analytics, Nia Health delivers scalable digital solutions that enhance medical decision-making, optimize research processes, and drive innovation in healthcare technology.
Driven by an interdisciplinary approach combining medical expertise and cutting-edge technological innovation, we are committed to transforming medical research through intelligent, data-driven solutions.
Address
Schlesische Str. 28
10997 Berlin
Germany
E-mail: vanessa.gebauer@niahealth.ai
Phone: +49 157 73658527
Internet: www.niahealth.ai
Contact person:
Dr. Vanessa Gebauer
Head of Business Development
E-mail: vanessa.gebauer@niahealth.ai
Phone: +49 157 73658527
Products & Services
Medtech Products:
Nia - a medical smartphone app designed to support patients with atopic dermatitis (eczema) in managing their condition.
The award-winning eczema app Nia is the most used medical eczema app in Europe. Nia was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company
Sorea - a medical smartphone app designed to help patients manage psoriasis, a chronic skin condition.
Based on the proven Nia Health platform, the psoriasis app Sorea was launched in 2020. Established technologies were applied to the needs of patients together with leading clinicians. Sorea is the first psoriasis app that has been approved as a medical device.
AI Severity classifier - The AI Severity Classifier is an advanced digital diagnostic technology that enables objective and quantitative assessment of inflammatory skin diseases through sophisticated machine vision and artificial intelligence.
Our proprietary platform combines machine vision AI and advanced machine learning to revolutionize medical research and patient monitoring. By delivering objective, quantifiable assessments across multiple medical domains, we enable precise dermatological, immunological, and pharmaceutical research insights.
Services:
Clinical Trial Support - Our company provides AI-driven diagnostic tools, mobile symptom tracking, and wearable data integration to support pharmaceutical companies in dermatology clinical trials. With existing partnerships with clinics and patient organizations, we can quickly engage and retain patients, ensuring reliable, real-time data on treatment efficacy and safety. Our platform reduces dropout rates, enhances trial efficiency, and delivers valuable real-world evidence, accelerating drug development and optimizing long-term outcomes.
Product Co-Development - Our development of digital health solutions focuses on creating innovative technologies that enhance patient care and clinical workflows. This involves identifying healthcare needs, designing user-friendly devices and software, and integrating advanced technologies like AI and telemedicine with existing systems. Through rigorous clinical validation, regulatory compliance, and scalability, these solutions ensure safety, efficiency, and interoperability, ultimately improving healthcare outcomes and operational efficiency.
Data and Technology Integration - Our healthcare data and technology integration service connects disparate systems and standardizes data exchange to enhance interoperability across healthcare platforms. Using industry protocols like HL7 FHIR, DICOM or MIO we enable seamless communication between electronic health records (EHRs), medical imaging, and clinical applications.
Dermatology Insight reporting - The service provides industrial partners with insights into their current and future markets using continuous and high frequent data streams improving their understanding of market dynamics and patient journeys. Our products allow patients to document their skin condition and identify patterns in disease progression more easily. This anonymized data provides insights into everyday treatment experiences that were previously difficult or impossible to access.
Nia
Nia, the first medical digital support for atopic dermatitis, helps sufferers deal with and understand their condition.
The app helps users track their symptoms, monitor skin health, and follow personalized treatment plans. Sufferers use Nia to document the progression of their disease with the help of photo documentation and clinical metrics, and to identify relapse triggers. Using machine vision, Nia assists patients in capturing high-quality images for consistent monitoring, even in difficult-to-reach areas. In addition, users can track their therapy and receive medical background knowledge about their disease based on multimedia and clinically validated content. The digital health application Nia provides real-time feedback and allows communication with healthcare professionals, offering personalized insights and enabling remote consultations. Nia aims to improve therapy adherence, streamline the management process, and enhance the quality of care for atopic dermatitis patients.
Sorea
Sorea is a medical smartphone app designed to help patients manage psoriasis, a chronic skin condition.
The app enables users to track their symptoms, monitor skin health, and follow personalized treatment plans. Through regular data collection and photo documentation, Sorea allows patients to monitor their condition over time. Using machine vision technology, the app helps users capture high-quality images of affected skin areas for consistent and accurate tracking, even in hard-to-reach places. Sorea also facilitates communication with healthcare professionals, enabling remote consultations and providing personalized treatment insights. The app aims to improve therapy adherence, streamline management, and enhance care for psoriasis patients.
-thumb.webp)
-thumb.webp)
-thumb.webp)
-thumb.webp)
-thumb.webp)
-thumb.webp)
-thumb.webp)
AI Severity Classifier
AI Severity classifier - The AI Severity Classifier is an advanced digital diagnostic technology that enables objective and quantitative assessment of inflammatory skin diseases through sophisticated machine vision and artificial intelligence.
Our advanced algorithm extracts and analyzes comprehensive skin condition data across diverse imaging environments, automatically determining the severity of inflammatory skin conditions like atopic dermatitis and psoriasis. The system generates individualized therapy suggestions, providing healthcare professionals with a standardized, reproducible method of tracking disease progression. By transforming real-world image data into precise medical insights, the Severity Classifier reduces subjective interpretation variability, supports precise treatment personalization, and delivers comprehensive scientific understanding for clinical practice and medical research.
